- Home
- CLDI vs KRKR Comparison
CLDI vs KRKR Comparison
Compare CLDI & KRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLDI | KRKR |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9M | 9.5M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | CLDI | KRKR |
|---|---|---|
| Price | $1.52 | $4.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 217.9K | 3.4K |
| Earning Date | 11-13-2025 | 09-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $30,966,526.00 |
| Revenue This Year | N/A | $182.55 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.10 | $2.76 |
| 52 Week High | $26.04 | $21.36 |
Technical Indicators
Market Signals| Indicator | CLDI | KRKR |
|---|---|---|
| Relative Strength Index (RSI) | 52.61 | 40.73 |
| Support Level | $1.38 | $4.11 |
| Resistance Level | $1.55 | $4.85 |
| Average True Range (ATR) | 0.09 | 0.26 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 92.42 | 43.87 |
Price Performance
Historical ComparisonAbout CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.